AbbVie to Present at the 43rd Annual J.P. Morgan Healthcare Conference
AbbVie (ABBV) has announced its upcoming participation in the 43rd Annual J.P. Morgan Healthcare Conference. The company's management will engage in a fireside chat on Wednesday, January 15, 2025, at 10:15 a.m. Central time.
Investors and interested parties can access a live audio webcast of the presentation through AbbVie's Investor Relations website at investors.abbvie.com. For those unable to attend the live session, an archived version will be made available later the same day.
AbbVie (ABBV) ha annunciato la sua prossima partecipazione al 43掳 Congresso Annuale J.P. Morgan Healthcare. La direzione dell'azienda parteciper脿 a una chiacchierata informale il mercoled矛 15 gennaio 2025, alle 10:15 ora centrale.
Investitori e parti interessate potranno accedere a una diretta audio della presentazione tramite il sito di Relazioni con gli Investitori di AbbVie su investors.abbvie.com. Per coloro che non possono partecipare alla sessione dal vivo, una versione registrata sar脿 disponibile pi霉 tardi lo stesso giorno.
AbbVie (ABBV) ha anunciado su pr贸xima participaci贸n en la 43陋 Conferencia Anual de Salud J.P. Morgan. La direcci贸n de la empresa participar谩 en una charla informal el mi茅rcoles 15 de enero de 2025, a las 10:15 a.m. hora central.
Los inversores y partes interesadas podr谩n acceder a una transmisi贸n de audio en vivo de la presentaci贸n a trav茅s del sito de Relaciones con Inversores de AbbVie en investors.abbvie.com. Para quienes no puedan asistir a la sesi贸n en vivo, se har谩 disponible una versi贸n grabada m谩s tarde ese mismo d铆a.
AbbVie (ABBV)电� 鞝�43須� 鞐半 J.P. Morgan 項姢旒�鞏� 旎嵓霟办姢鞐� 瓿� 彀胳劃頃� 鞓堨爼鞚措澕瓿� 氚滍憸頄堨姷雼堧嫟. 須岇偓鞚� 瓴届榿歆勳潃 2025雲� 1鞗� 15鞚� 靾橃殧鞚� 鞓れ爠 10:15 欷戩暀 響滌鞁�鞐� 牍勱车鞁� 雽�頇旍棎 彀胳棳頃� 瓴冹瀰雼堧嫟.
韴瀽鞛愳檧 甏�鞁� 鞛埖鐢 雼轨偓鞛惖鐢 AbbVie鞚� 韴瀽鞛� 甏�瓿� 鞗轨偓鞚错姼鞚� investors.abbvie.com鞚� 韱淀暣 氚滍憸鞚� 霛检澊敫� 鞓る敂鞓� 鞗轨簮鞀ろ姼鞐� 鞝戧芳頃� 靾� 鞛堨姷雼堧嫟. 鞁れ嫓臧� 靹胳厴鞐� 彀胳劃頃� 靾� 鞐喌鐢 攵勲摛鞚� 鞙勴暣 臧欖潃 雮� 雮橃鞐� 鞎勳勾鞚措笇 氩勳爠鞚� 鞝滉车霅� 鞓堨爼鞛呺媹雼�.
AbbVie (ABBV) a annonc茅 sa prochaine participation 脿 la 43猫me Conf茅rence Annuelle J.P. Morgan Healthcare. La direction de l'entreprise participera 脿 une discussion informelle le mercredi 15 janvier 2025, 脿 10h15 heure centrale.
Les investisseurs et les parties int茅ress茅es pourront acc茅der 脿 un webcast audio en direct de la pr茅sentation via le site des Relations Investisseurs d'AbbVie sur investors.abbvie.com. Pour ceux qui ne peuvent pas assister 脿 la session en direct, une version archiv茅e sera disponible plus tard dans la journ茅e.
AbbVie (ABBV) hat seine bevorstehende Teilnahme an der 43. j盲hrlichen J.P. Morgan Healthcare-Konferenz bekannt gegeben. Das Management des Unternehmens wird am Mittwoch, den 15. Januar 2025, um 10:15 Uhr Central Time an einem informellen Gespr盲ch teilnehmen.
Investoren und interessierte Parteien k枚nnen 眉ber die Investor Relations-Website von AbbVie unter investors.abbvie.com auf ein Live-Audio-Webcast der Pr盲sentation zugreifen. F眉r diejenigen, die nicht an der Livesitzung teilnehmen k枚nnen, wird sp盲ter am selben Tag eine aufgezeichnete Version verf眉gbar sein.
- None.
- None.
A live audio webcast of the presentation will be accessible through AbbVie's Investor Relations website at . An archived edition of the session will be available later that day.
About AbbVie
AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas 鈥� immunology, oncology, neuroscience, and eye care 鈥� and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at . Follow @abbvie on 听, , , and 听
View original content to download multimedia:
SOURCE AbbVie
FAQ
When is AbbVie (ABBV) presenting at the 2025 J.P. Morgan Healthcare Conference?
How can investors watch AbbVie's presentation at the J.P. Morgan Healthcare Conference?
What type of presentation will ABBV give at the J.P. Morgan Healthcare Conference?
Will there be a replay available of AbbVie's J.P. Morgan Healthcare Conference presentation?
